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(3R1N, 4R1N), or no (3R0N, 4R0N) inserts of 29 amino
acids each near the amino-terminus by inclusion of exons
2, 3, or exon 2 or none, respectively. The major
established function of tau is its interaction with the major
microtubule protein subunit tubulin that results in the
promotion of assembly of tubulin into microtubules and
the maintenance of these structures. Microtubules are
required for the axoplasmic transport which is too critical
for neuronal function to depend solely on a single protein.
The backup neuronal MAPs are the two high molecular
weight proteins (HMW), MAP1 and MAP2 which, like tau,
contain the microtubule binding domains/repeats and
essentially perform the same function as tau in promoting
assembly and maintaining the structure of microtubules.
While tau in normal mature neurons is mostly localized in
the axon, the HMW MAPs have largely somatodendritic
distribution.

INTRODUCTION
Alzheimer’s disease, the major cause of dementia in
middle- to old-age individuals, is characterized
histopathologically by two brain lesions, namely the
neurofibrillary
degeneration
of
abnormally
hyperphosphorylated tau and the amyloidosis.
Neurofibrillary degeneration is seen as intraneuronal
neurofibrillary tangles of paired helical filaments (PHF)
mixed with straight filaments (SF), neuropil threads, and
dystrophic neurites surrounding the amyloid core in
neuritic (senile) plaques, the second hallmark lesion. The
major protein subunit of PHF/SF is the microtubule
associated protein (MAP) tau in an abnormally
hyperphosphorylated state. 1,2 In AD, the number of
neurofibrillary tangles directly correlates with the degree of
dementia. The number of plaques does not correlate with
dementia and some of the normal aged individuals have
as much amyloid plaque load as in typical cases of AD.
Thus, amyloid by itself might not be sufficient to produce
the clinical expression of the disease but it might still play
a synergistic role in individuals with neurofibrillary
degeneration in producing the disease.

Tau is a phosphoprotein and its biological activity is
regulated by its degree of phosphorylation.
Hyperphosphorylation depresses the ability of tau to bind
to tubulin and promote its assembly into microtubules. In
Alzheimer disease (AD), tau is abnormally
hyperphosphorylated.6

The etiology and pathogenesis of neurofibrillary
degeneration and therapeutic strategies have been the
subject of several recent reviews.3,4 In this article, the
central role of tau protein in the etiopathogenesis of AD
and related tauopathies is described.

Since the discovery of tau as the major protein subunit of
PHF in 1986, a number of post-translational
modifications, i.e. abnormal hyperphosphorylation,
ubiquitination, glycation, N-glycosylation, O-GlcNAcylation,
polyamination, nitration and truncation, have been
implicated in its pathology. 1,7 To date, the most
established cause of dysfunction of tau in AD and related
tauopathies is its abnormal hyperphosphorylation.
Neurofibrillary
degeneration
of
abnormally
hyperphosphorylated tau is also seen in several other
human neurodegenerative disorders, which include
frontotemporal dementia, Pick disease, corticobasal
degeneration, dementia pugilistica and progressive
supranuclear palsy. In every one of these disorders, called

Normal and Pathological Taus:
Tau protein is the major neuronal MAP. It is encoded by a
single gene but alternate splicing of its pre-mRNA in the
brain results in several molecular isoforms.5 In the human
brain, there are six molecular isoforms, generated by
exclusion (3R2N, 3R1N, 3R0N) or inclusion (4R2N,
4R1N, 4R0N) of exon 10 which codes for 31 or 32 amino
acids near the carboxy-terminus, and 2 (3R2N, 4R2N), 1
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tauopathies, the accumulation of the abnormally
hyperphosphorylated tau is associated with neurofibrillary
degeneration and dementia. The discovery of mutations
in tau gene and their cosegregation with the disease in
the inherited frontotemporal dementia with Parkinsonismlinked to chromosome-17 (FTDP-17) has established that
abnormalities in tau protein as a primary event can lead to
neurodegeneration and dementia.8

Tau hyperphosphorylation
1.
2.
3.
4.
5.

The abnormal hyperphosphorylation of tau appears to
precede its accumulation in the affected neurons in AD. In
vitro hyperphosphorylation promotes tau’s assembly into
bundles of PHF and SF. 9,10 Induction of
hyperphosphorylation of tau in metabolically active rat
brain slices by inhibition of PP-2A activity with okadaic
acid, and in normal adult rats by activation of protein
kinase-A, leads to accumulation of tau. 11,12 The
abnormally hyperphosphorylated tau was discovered not
only in neurofibrillary tangles but also in cytosol from AD
brains.1,6 Quantitative immunohistochemical studies with
monoclonal antibody (mAb) Tau-1 have revealed deposits
of only abnormally phosphorylated tau, but not normal
tau, in neurons without tangles (stage 0 tangles) both in
Alzheimer and in normal aged hippocampi. 13 Tau in
tangles, mostly ghost tangles, is known to be
ubiquitinated,
whereas
the
abnormally
hyperphosphorylated tau isolated from AD brain cytosol
was found to have no ubiquitin reactivity. 14 All these
studies suggest that the abnormal hyperphosphorylation of
tau precedes its accumulation into neurofibrillary
tangles.15

have been found to cause familial AD, have, to date,
shown to produce AD-like extensive tau pathology in
transgenic mice overexpressing these human mutant
proteins. On the other hand, overexpression of FTDP-17
mutant taus and as well its co-expression with APP/PS1
mutations in transgenic mice have been found to produce
neurofibrillary tangles of SF/PHF of abnormally
hyperphosphorylated tau.18,19 A recent study has shown
that, on hyperphosphorylation, murine tau self assembles
into tangles of filaments (PHF/SF) as readily as the
corresponding human brain tau, suggesting that the
protein phosphorylation/dephosphorylation system is
probably more stable and resistant to changes in the lower
order than the higher order species, such as humans.20
Consistent with these suggestions, overexpression of p25,
the activator of cdk5 in transgenic mice which promotes
the hyperphosphorylation of tau, has been found to result
in self assembly of filaments, though sparsely.21, 22
Tau in AD and other tauopathies appears to be mostly
intact.1,2,6 However, immunohistochemically, tau in AD
neurofibrillary tangles has been shown to be truncated
both at Glu 391 and Ser-421.23,24 These truncated taus
have been shown to be associated with apoptosis in
cultured cells. However, what percentage of tau is
truncated at these sites at what stage of neurofibrillary
pathology in AD brain has not been reported, to date.
Furthermore, unlike the monomeric truncated tau
employed in the cell biological studies, this protein
polymerized in neurofibrillary tangles/PHF might not have
any biological activity. Since Alzheimer neurofibrillary
degeneration takes place over a period of several months
to years, it should not be surprising to have certain
truncated taus in AD brain, especially resulting from
neurofibrillary tangles which are exposed to hydrolases,
both in the affected neurons and as well as in the case of
the ghost tangles in the extracellular space. Both N- and
C-terminal regions flanking the microtubule binding
domains of tau are inhibitory to its self assembly into
filaments. 10 Thus, neutralization of these inhibitory
domains by abnormal hyperphosphorylation, a major
mechanism probably involved in AD and related
tauopathies, or partially by truncation might result in the
formation of neurofibrillary tangles.10 Consistent with this

One of the possibilities is that the abnormal
hyperphosphorylation of tau might be due to a
conformational change(s) in tau in the diseased brain,
which might make it a better substrate for phosphorylation
and or a worse substrate for dephosphorylation.
In
inherited cases of FTDP-17, where the disease is caused
by certain missense mutations in tau, these mutations
make tau a more favorable substrate for
hyperphosphorylation by brain protein kinases.9 Such a
scenario is less likely in AD because, in this disease, tau is
not the only neuronal protein which is
hyperphosphorylated as a result of the protein
phosphorylation/ dephosphorylation imbalance.
Biochemically, tubulin and neurofilaments and
immunohistochemically neurofilaments and MAP1B have
been found to be hyperphosphorylated in AD brain.
Furthermore, both the cytosolic- and PHF-abnormally
hyperphosphorylated taus are readily dephosphorylated by
phosphatases in vitro. 2, 16, 17
The neurofibrillary degeneration of the Alzheimer type is
seen only sparsely in aged animals and in experimentally
induced conditions. None of the mutations in amyloid
precursor protein (APP), presenilin-1 or presenilin-2, which
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Inhibits its ability to promote microtubule assembly
Sequesters normal tau and other MAPs, thereby
preventing their association with microtubules
Disrupts preformed microtubules
Promotes its self assembly into bundles of paired
helical filaments, i.e., neurofibrillary tangles
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Figure 1. Neurofibrillary Degeneration. Intracellular transport of proteins, lipids, synaptic vesicles filled with
neurotransmitters, and other organelles are essential for the growth, survival, and functioning of a neuron.
Microtubules serve as the railroad tracks along which the axonal transport takes place. Tau protein acts as
the railroad ties, stabilizing the railroad tracks/microtubules. This activity of tau is regulated by its degree of
phosphorylation; hyperphosphorylation depresses this activity. Abnormal hyperphosphorylation of tau in
Alzheimer disease and related tauopathies not only results in the loss of the railroad tie function of this
protein but also causes the disruption of the microtubule network, resulting in a seriously compromised
axonal transport. Consequently the neurites start retracting and the affected neuron undergoes a retrograde
degeneration. This neurofibrillary degeneration is a slow but chronic progressive process. A neuron with a
neurofibrillary tangle lingers on up to several years in the diseased brain before the cell dies, leaving behind
what is called a ≈ghost tangle∆ or a ≈tombstone∆ floating in the extracellular space in the brain parenchyma.

the protein such that it becomes a more favorable
substrate to brain protein kinases.9 The mutated taus are
more rapidly hyperphosphorylated and can self assemble
at a lower level of hyperphosphorylation than the wild type
tau.

hypothesis, a transgenic rat model overexpressing
truncated human tau has been shown to produce a
significant number of neurofibrillary tangles and tau in
these lesions is abnormally hyperphosphorylated.25
Abnormally hyperphosphorylated tau isolated from AD
brain readily polymerizes into tangles of PHF/SF in vitro
and these self assembly conditions, which are consistent
to the findings in AD and other tauopathies, do not require
any co-factor. 10 This self assembly of tau requires
hyperphosphorylation because dephosphorylation inhibits
it. Unlike dephosphorylation, deglycosylation of AD tau
does not inhibit its ability to self assemble into
filaments. 26
Furthermore,
on
in
vitro
hyperphosphorylation, each of the six recombinant human
brain tau isoforms self assemble into PHF/SF. All these
findings taken together suggest that the abnormal
hyperphosphorylation is probably required to cause the
assembly of tau into filaments and might be the molecular
mechanism involved in the formation of tau lesions in AD
and other tauopathies.

Molecular basis of neurofibrillary degeneration:
In AD brains the levels of tau, but not the mRNA for this
protein, are four- to eight-fold increased as compared to
age-matched control brains and this increase is in the
form of the abnormally hyperphosphorylated tau.27 The
abnormally hyperphosphorylated tau is found in AD brain
in two subcellular pools, i.e. (i) as polymerized into
neurofibrillary tangles of PHF mixed with straight filaments
(SF); and (ii) as non-fibrillized form in the cytosol.6,13,15
The tau polymerized into neurofibrillary tangles is
apparently inert and only on enzymatic dephosphorylation
in vitro when released from PHF/tangles it behaves like
normal tau in promoting microtubule assembly. 16 In
contrast, the cytosolic abnormally hyperphosphorylated
tau (AD P-tau) which can be as much as ~ 40% of the
total abnormal tau in AD brain does not interact with

The FTDP-17 mutations appear to alter conformation of
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Figure 2. Molecular mechanism of neurofibrillary degeneration. Normal tau interacts with tubulin and stimulates its assembly and
stabilizes microtubules. In AD brain, because of an imbalance in tau kinase and phosphatase activities and a change in its
conformation induced by other post-translational changes or mutations as in inherited cases of FTDP-17, tau becomes abnormally
hyperphosphorylated. The abnormally hyperphosphorylated tau resulting from any one of the above causes behaves as an
inhibitory/toxic protein; it not only is unable to stimulate microtubule assembly and bind to microtubules, but also sequesters normal
tau, MAP 1A / MAP1B and MAP2, and leads to inhibition of assembly and disruption of microtubules. The breakdown of the
microtubule network in the affected neurons compromises axonal transport, leading to retrograde degeneration which, in turn, results
in dementia. The association between the AD P-tau and normal tau in the presence of glycosylation results in the formation of
neurofibrillary tangles. The tangles are ubiquitinated for degradation by the non-lysosomal ubiquitin pathway, but apparently this
degradation, if any, is minimal. Unlike the non-polymerized abnormally hyperphosphorylated tau, the neurofibrillary tangles are
inert but, with disease progression, these lesions grow in size and eventually might physically choke the affected cells to death.
Illustration adapted from www.nia.gov

the
wild-type
human
tau
for
abnormal
hyperphosphorylation by brain protein kinases in vitro.9
These mutated taus become hyperphosphorylated at a
faster rate and self-aggregate into filaments more readily,
i.e. at a phosphorylation stoichiometry of 4-6 as
compared with 10 or more in the case of the wild-type
protein. These faster kinetics of the hyperphosphorylation
of the mutated tau might explain a relatively early onset,
severity and autosomal dominance of the disease in the
inherited FTDP-17 cases.

tubulin/microtubules but instead sequesters normal tau,
MAP1A/ MAP1B and MAP2, causing inhibition and
disassembly of microtubules in vitro. 15,28-31 The
association between ADP-tau and normal tau is not
saturable and in vitro results in the formation of tangles of
~ 2.1 mm filaments.29 The association between AD P-tau
and MAP1A/ MAP1B or MAP2 is weaker than that
between the AD P-tau and normal tau and does not result
in the formation of filaments.28 This inhibitory activity of
the AD P-tau appears to be solely due to its abnormal
hyperphosphorylation because dephosphorylation by
alkaline phosphatase, protein phosphatase (PP)-2A, PP2B and to a lesser degree by PP-1 converts the abnormal
tau into a normal-like protein which can promote the
microtubule assembly in vitro.16,28-30,32 The sequestration
of functional tau by the abnormally hyperphosphorylated
tau causes disruption of the microtubule network and
thereby leads to neurodegeneration (Figs. 1 and 2).

The six human tau isoforms are differentially sequestered
by AD P-tau, in vitro. 10 AD P-tau also inhibits the
assembly and disrupts microtubules pre-assembled with
each tau isoform with an efficiency which corresponds
directly to the degree of interaction with these isoforms. In
vitro hyperphosphorylation of recombinant tau converts it
into an AD P-tau-like state in sequestering normal tau and
inhibiting microtubule assembly. The preferential
sequestration of 4R taus and taus with amino terminal
inserts explains both (i) why fetal brain (fetal tau is with
3R and no N-terminal inserts) is protected from Alzheimer
neurofibrillary pathology and (ii) why intronic mutations

Several missense mutations in tau cosegregate with the
disease in FTDP-17.8 Four of these missense mutations,
G272V, P301L, V337M and R406W which have been
studied to date make tau a more favorable substrate than
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Figure 3. A proposed mechanism of tau-induced neurotoxicity in AD. Chronic neuronal insult in AD leads to the
activation of extra-synaptic NMDA receptors. Intracellular levels of a src family non-receptor tyrosine kinase, fyn,
are increased in AD. Acute neuronal insults, like ischemia, bring about the formation of a ternary activator
complex by which Fyn interacts with the NMDAR thereby activating the receptor channel. Fyn further activates
extra-synaptic NMDA receptor by tyrosine phosphorylation of the NR2B subunit causing continued Ca+2 influx
into the cytoplasm. Fyn also activates GSK-3? and cdk-5, which phosphorylate tau at several key serine/threonine
residues. Fyn phosphorylates the N-terminal tyrosine 18 residue on tau. Hyperphosphorylation of tau leads to a
change in its secondary structure that brings about its dissociation from the microtubules, and an ≈unmasking∆ of
toxic domains probably near its N-terminal. Ca+2 activates calpain, which cleaves non-hyperphosphorylated tau
into fragments, some of which are toxic to the cell. High intracellular Ca+2 leads to mitochondrial dysfunction.
Chronic over-activation of extra-synaptic NMDAR sends a CREB shut-off signal whereby levels of phospho-CREB
decline. This leads to decreased production of pro-survival signals like BDNF.
Levels of I2PP2A, a PP-2A inhibitor, are increased in AD and the inhibitor is selectively translocated from the
neuronal nucleus to the cytoplasm. PP-2A is also inhibited by activation of the NMDA receptor. This further
contributes towards hyperphosphorylation of tau. All these events lead to cellular dysfunction and neuronal death
over a period of time.
Adapted from Chohan and Iqbal (2006). J Alzheimers Dis. 10(1):81-7

disassembly of microtubules the affected neurons
promote the self-assembly of the abnormal tau into
tangles of PHF. The fact that the tangle-bearing neurons
seem to survive many years is consistent with such a selfdefense role of the formation of tangles.35 The AD P-tau
readily self-assembles into tangles of PHF/SF in vitro
under physiological conditions of protein concentration,
pH, ionic strength and reducing conditions.10 Furthermore,
dephosphorylation inhibits the self assembly of AD P-tau
into PHF/SF, and the in vitro abnormal
hyperphosphorylation of each of the six recombinant
human brain tau isoforms promotes their assembly into
tangles of PHF/SF. Thus, all these studies taken together
demonstrate the pivotal involvement of abnormal
hyperphosphorylation in neurofibrillary degeneration (Fig.
3).

seen in certain inherited cases of FTDP-17, which result in
alternate splicing of tau mRNA, and consequently an
increase in 4R:3R ratio, lead to neurofibrillary
degeneration and the disease. In vitro at a
phosphorylation stoichiometry of ~ 4 and above the
hyperphosphorylated tau sequesters normal tau, whereas
it requires a stoichiometry of 10 or more to self-aggregate
into filaments.9 On aggregation into filaments tau loses its
ability to sequester normal tau. Furthermore, AD P-tau,
but not PHF, inhibits regeneration of microtubule network
in detergent-extracted PC12 cells, indicating that the
formation of filaments might be initiated as a self defense
response by the affected neurons.31
The abnormal hyperphosphorylation of tau makes it
resistant to proteolysis by the calcium activated neutral
protease and most likely it is because of this reason the
level of tau is several-fold increased in AD.16,27,32 Some
increase in tau level in AD brain can also result from the
activation of p70 S6 kinase which upregulates the
translation of tau.33,34 It is likely that to neutralize the AD
P-tau’s ability to sequester normal MAPs and cause
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